Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetic–Pharmacodynamic Relationship: Problems01:24

Pharmacokinetic–Pharmacodynamic Relationship: Problems

The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Biopharmaceutical Factors Influencing Drug Product Design: Overview01:22

Biopharmaceutical Factors Influencing Drug Product Design: Overview

Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though pharmacologically...
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-world treatment patterns among advanced non-small cell lung cancer patients in the US.

Innovations in pharmacy·2026
Same author

Cybersecurity and Privacy Risks of Generative AI Mental-Health Chatbots: A Systematic Review and Regulatory Framework.

Journal of multidisciplinary healthcare·2026
Same author

Value, Structure, and Curriculum in US Graduate Health Informatics Programs: Cross-Sectional Study.

JMIR medical education·2026
Same author

Current perspectives on bioceramic sealers in endodontics: A review.

Bioinformation·2026
Same author

How the Federal Home Loan Bank Board Shared Home Owners' Loan Corporation Maps With Private Industry: Elucidating Redlining Causation in Public Health Research.

American journal of public health·2026
Same author

Enhancing community pharmacists' role in research: Insights and challenges in recruiting through pharmacy practice-based research networks.

Journal of the American Pharmacists Association : JAPhA·2026
Same journal

Findings from the 2025 AMCP Foundation Symposium: Health Optimization 2.0.

Journal of managed care & specialty pharmacy·2026
Same journal

AMCP Market Insights: Managed care considerations in Barth syndrome.

Journal of managed care & specialty pharmacy·2026
Same journal

Association between comorbid depression, antidepressant adherence, and disease-modifying therapy adherence among Texas Medicaid patients with sickle cell disease.

Journal of managed care & specialty pharmacy·2026
Same journal

Incremental health care resource utilization, costs, and predictors of high costs in generalized myasthenia gravis.

Journal of managed care & specialty pharmacy·2026
Same journal

Real-world switching and switch-back patterns among patients transitioning from adalimumab to biosimilars in the United States (February 2023 to August 2025).

Journal of managed care & specialty pharmacy·2026
Same journal

The effectiveness and value of B-cell-directed therapies for the treatment of immunoglobulin A nephropathy.

Journal of managed care & specialty pharmacy·2026
See all related articles

Related Experiment Video

Updated: May 23, 2026

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

Predicting pharmacy choice for managed care network design.

Michael Irungu1, Suhila Sawesi1, Mohamed Rashrash2

  • 1Health Informatics and Bioinformatics, Department of Information Sciences and Technologies, College of Computing, Grand Valley State University, Grand Rapids, MI.

Journal of Managed Care & Specialty Pharmacy
|May 21, 2026
PubMed
Summary
This summary is machine-generated.

Patient characteristics influence pharmacy choice. Ensemble machine learning models, like XGBoost, better predict pharmacy type selection than logistic regression, capturing complex patient-provider relationships for improved medication access.

More Related Videos

A Workflow for Lipid Nanoparticle (LNP) Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models (SVEM)
13:54

A Workflow for Lipid Nanoparticle (LNP) Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models (SVEM)

Published on: August 18, 2023

Related Experiment Videos

Last Updated: May 23, 2026

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

A Workflow for Lipid Nanoparticle (LNP) Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models (SVEM)
13:54

A Workflow for Lipid Nanoparticle (LNP) Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models (SVEM)

Published on: August 18, 2023

Area of Science:

  • Health Services Research
  • Pharmacoepidemiology
  • Health Informatics

Background:

  • Pharmacy type selection is crucial for medication access and adherence.
  • Traditional logistic regression may oversimplify complex patient characteristics influencing pharmacy choice.

Purpose of the Study:

  • To identify patient characteristics associated with pharmacy type selection.
  • To compare the predictive performance of logistic regression against ensemble machine learning models for pharmacy choice.

Main Methods:

  • Cross-sectional analysis of 1,502 adults from the 2021 National Consumer Survey on Medication Experience.
  • Compared logistic regression with random forest and XGBoost using 5-fold cross-validation and held-out test data.
  • Assessed model discrimination using the area under the receiver operating characteristic curve.

Main Results:

  • Ensemble models, particularly XGBoost, showed superior discrimination compared to logistic regression.
  • Key predictors of pharmacy type included prior mail-order use, chronic conditions, income, and US region.
  • Ensemble models effectively captured nonlinear relationships between patient factors and pharmacy choice.

Conclusions:

  • Pharmacy selection is influenced by patient demographics and health status, varying by pharmacy type.
  • The analytical approach significantly impacts conclusions drawn about pharmacy choice.
  • Findings underscore the importance of advanced modeling for understanding medication access and informing future research.